Market Cap 7.51M
Revenue (ttm) 7.69M
Net Income (ttm) -63.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -820.81%
Debt to Equity Ratio 0.00
Volume 29,000
Avg Vol 26,722
Day's Range N/A - N/A
Shares Out 1.92M
Stochastic %K 0%
Beta 0.94
Analysts Sell
Price Target $6.00

Company Profile

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreat...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 665 9295
Address:
900 Chesapeake Drive, Redwood City, United States
SheriffGrover
SheriffGrover Mar. 14 at 12:02 PM
$BOLT well I didn't find any strange things in the 10K ... but it's crystal clear somethings got to give this year ... cash runway into '27 ... In the meantime MC @ $ 7.5 million ....
0 · Reply
SheriffGrover
SheriffGrover Mar. 13 at 8:38 AM
$BOLT Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update https://finance.yahoo.com/news/bolt-biotherapeutics-reports-fourth-quarter-200500330.html
0 · Reply
Sam1381
Sam1381 Mar. 13 at 12:03 AM
$BOLT What is your opinions about the results today? Do you think if the stock is a buy anytime soon?
0 · Reply
Revempire
Revempire Mar. 8 at 5:27 AM
$BOLT Investors are watching for initial Phase 1 data for BDC-4182 (targeting gastric cancer), expected in the second half of 2026.
0 · Reply
SheriffGrover
SheriffGrover Mar. 4 at 12:32 PM
$BOLT FYI : https://investors.boltbio.com/static-files/397f2c02-b515-44a2-a108-6e1302a91a98
0 · Reply
skyrockets_Inc
skyrockets_Inc Mar. 2 at 6:14 PM
$BOLT I think the risk here is just the timing, since there are no known catalysts until Q3 it's no wonder that the stock has dropped as impatient investors moved on to other ones. I'm guilty of selling a bit as well in the 6's (only 1/3 of my position) only because I needed the money to put into another play w/ quicker timing (RLYB). That one finalized today's w/ RM so I'm buying back my original position in BOLT . Everything is still good here, cash position, big pharma, tutes/insiders, etc. The only problem is w/ no known catalysts until Q3 this could continue to linger and/or drift down. But also could have an upknown PR any random day and be up 100-200% so it's worth keeping a position in sized appropriately. Will re-evaluate once 10q comes out .
1 · Reply
SheriffGrover
SheriffGrover Feb. 27 at 5:07 PM
$BOLT Nan Fung group still unloading ..... 40K + shares in 9 days ... not very encouraging i must say ...... What's your take Skyrockets Inc ?? TIA
3 · Reply
JDD808
JDD808 Feb. 27 at 4:08 PM
$BOLT very overdue for an update here
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 24 at 9:58 PM
$BOLT RSI: 36.70, MACD: -0.2644 Vol: 0.65, MA20: 5.47, MA50: 5.67 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SheriffGrover
SheriffGrover Feb. 24 at 2:36 PM
$BOLT Bolt Biotherapeutics to Participate in Upcoming March Conferences https://finance.yahoo.com/news/bolt-biotherapeutics-participate-upcoming-march-130000477.html
1 · Reply
Latest News on BOLT
SheriffGrover
SheriffGrover Mar. 14 at 12:02 PM
$BOLT well I didn't find any strange things in the 10K ... but it's crystal clear somethings got to give this year ... cash runway into '27 ... In the meantime MC @ $ 7.5 million ....
0 · Reply
SheriffGrover
SheriffGrover Mar. 13 at 8:38 AM
$BOLT Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update https://finance.yahoo.com/news/bolt-biotherapeutics-reports-fourth-quarter-200500330.html
0 · Reply
Sam1381
Sam1381 Mar. 13 at 12:03 AM
$BOLT What is your opinions about the results today? Do you think if the stock is a buy anytime soon?
0 · Reply
Revempire
Revempire Mar. 8 at 5:27 AM
$BOLT Investors are watching for initial Phase 1 data for BDC-4182 (targeting gastric cancer), expected in the second half of 2026.
0 · Reply
SheriffGrover
SheriffGrover Mar. 4 at 12:32 PM
$BOLT FYI : https://investors.boltbio.com/static-files/397f2c02-b515-44a2-a108-6e1302a91a98
0 · Reply
skyrockets_Inc
skyrockets_Inc Mar. 2 at 6:14 PM
$BOLT I think the risk here is just the timing, since there are no known catalysts until Q3 it's no wonder that the stock has dropped as impatient investors moved on to other ones. I'm guilty of selling a bit as well in the 6's (only 1/3 of my position) only because I needed the money to put into another play w/ quicker timing (RLYB). That one finalized today's w/ RM so I'm buying back my original position in BOLT . Everything is still good here, cash position, big pharma, tutes/insiders, etc. The only problem is w/ no known catalysts until Q3 this could continue to linger and/or drift down. But also could have an upknown PR any random day and be up 100-200% so it's worth keeping a position in sized appropriately. Will re-evaluate once 10q comes out .
1 · Reply
SheriffGrover
SheriffGrover Feb. 27 at 5:07 PM
$BOLT Nan Fung group still unloading ..... 40K + shares in 9 days ... not very encouraging i must say ...... What's your take Skyrockets Inc ?? TIA
3 · Reply
JDD808
JDD808 Feb. 27 at 4:08 PM
$BOLT very overdue for an update here
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 24 at 9:58 PM
$BOLT RSI: 36.70, MACD: -0.2644 Vol: 0.65, MA20: 5.47, MA50: 5.67 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SheriffGrover
SheriffGrover Feb. 24 at 2:36 PM
$BOLT Bolt Biotherapeutics to Participate in Upcoming March Conferences https://finance.yahoo.com/news/bolt-biotherapeutics-participate-upcoming-march-130000477.html
1 · Reply
TheMorningStew
TheMorningStew Feb. 23 at 5:48 PM
$BOLT PR gets it to double - small float action
1 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 20 at 5:18 PM
$BOLT Been slowly buying bits when it dropped into 4's. Waiting now to see how price moves
0 · Reply
PriceActionSocietytrades
PriceActionSocietytrades Feb. 19 at 7:39 PM
0 · Reply
SheriffGrover
SheriffGrover Feb. 19 at 2:04 PM
$BOLT Marketwire quote from Genmab CEO : He points out that Genmab is still looking for smaller complementary acquisitions - Genmab's CEO calls them "token" acquisitions. - But we are not in the market with a view to major acquisitions. - Now it's about focus and execution, says Jan van de Winkel. Now let's hope and pray BOLT is in the picture !!;o)
1 · Reply
SheriffGrover
SheriffGrover Feb. 18 at 7:37 PM
$BOLT Hmmmmm new all time low ....... geezzzzz
1 · Reply
trendricky
trendricky Feb. 17 at 8:26 AM
$BOLT Pre-revenue EV or tech; speculative
0 · Reply
Kevingeorge
Kevingeorge Feb. 14 at 7:52 PM
$BOLT swear its been a rough two years hopefully this just hits 17 soon!
0 · Reply
SheriffGrover
SheriffGrover Feb. 10 at 3:43 PM
$BOLT well enough now BOLT ..... come on ...
1 · Reply
ZoneRaider
ZoneRaider Feb. 9 at 11:16 AM
$BOLT is an electric vehicle charging or automotive technology company; it faces the classic challenge of building infrastructure ahead of demand, requiring large capital outlays with uncertain near-term returns.
1 · Reply
jschor88
jschor88 Feb. 6 at 2:38 PM
$BOLT 👀
0 · Reply
JL_TradeZ
JL_TradeZ Feb. 5 at 3:15 PM
🚨SPECIAL PLAY $BOLT Seeing a heavy cluster of Form 4 insider buys here. The CEO, COO, and multiple directors are all stepping in again after the pullback. Cash is over 30M with a market cap around 10M, which stands out. Float is small, and institutions are still involved. This cooled off after the run but didn’t fall apart. If it goes, I’m looking toward 7-8+ and extension if momentum rotates back into small-cap biotech
3 · Reply